How does Boston Scientific (BSX) make money?

Boston Scientific (BSX) primarily makes money through Cardiovascular, which accounts for 66% of total revenue. For TTM through Q1 2026, Boston Scientific generated $20.61B in total revenue with a net profit margin of 17.2%.

What is Boston Scientific (BSX) gross profit margin?

Boston Scientific (BSX) reported a gross profit margin of 70.4% for TTM through Q1 2026, equivalent to $14.52B in gross profit. This means Boston Scientific retains 70.4% of each revenue unit after direct costs of production.

What is Boston Scientific (BSX) operating profit margin?

Boston Scientific (BSX) reported an operating profit margin of 20.1% for TTM through Q1 2026, equivalent to $4.15B in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.

What is Boston Scientific (BSX) net profit margin?

Boston Scientific (BSX) reported a net profit margin of 17.2% for TTM through Q1 2026, equivalent to $3.55B in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.

How much does Boston Scientific (BSX) invest in R&D?

Boston Scientific (BSX) invested $2.13B in research and development in TTM through Q1 2026 (10.3% of total revenue). R&D spending reflects investment in future products, services, and technologies.

How much does Boston Scientific (BSX) spend on capital expenditures?

Boston Scientific (BSX) spent $909.00M on capital expenditures in TTM through Q1 2026 (4.4% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.

What is Boston Scientific (BSX) free cash flow?

Boston Scientific (BSX) generated $3.63B in free cash flow for TTM through Q1 2026 (17.6% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.

What is Boston Scientific (BSX) effective tax rate?

Boston Scientific (BSX) had an effective tax rate of 4.9% for TTM through Q1 2026. This is the actual percentage of pre-tax income paid as income taxes.

How Boston Scientific (BSX) Makes Money: A Visual Guide

Boston Scientific (BSX) generated $20.61B in revenue, earning $3.55B in net profit (17.2% margin). Its largest revenue source is Cardiovascular (66% of revenue). Below is an interactive breakdown of how revenue flows through the income statement.

Boston Scientific (BSX) Income Statement Flow — TTM through Q1 2026

Calculated from the four most recent reported quarters, ending March 31, 2026 (reported March 31, 2026).

Frequently asked questions

How does Boston Scientific (BSX) make money?: Boston Scientific (BSX) primarily makes money through Cardiovascular, which accounts for 66% of total revenue. For TTM through Q1 2026, Boston Scientific generated $20.61B in total revenue with a net profit margin of 17.2%.
What is Boston Scientific (BSX) gross profit margin?: Boston Scientific (BSX) reported a gross profit margin of 70.4% for TTM through Q1 2026, equivalent to $14.52B in gross profit. This means Boston Scientific retains 70.4% of each revenue unit after direct costs of production.
What is Boston Scientific (BSX) operating profit margin?: Boston Scientific (BSX) reported an operating profit margin of 20.1% for TTM through Q1 2026, equivalent to $4.15B in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.
What is Boston Scientific (BSX) net profit margin?: Boston Scientific (BSX) reported a net profit margin of 17.2% for TTM through Q1 2026, equivalent to $3.55B in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.
How much does Boston Scientific (BSX) invest in R&D?: Boston Scientific (BSX) invested $2.13B in research and development in TTM through Q1 2026 (10.3% of total revenue). R&D spending reflects investment in future products, services, and technologies.
How much does Boston Scientific (BSX) spend on capital expenditures?: Boston Scientific (BSX) spent $909.00M on capital expenditures in TTM through Q1 2026 (4.4% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.
What is Boston Scientific (BSX) free cash flow?: Boston Scientific (BSX) generated $3.63B in free cash flow for TTM through Q1 2026 (17.6% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.
What is Boston Scientific (BSX) effective tax rate?: Boston Scientific (BSX) had an effective tax rate of 4.9% for TTM through Q1 2026. This is the actual percentage of pre-tax income paid as income taxes.

Data & methodology

What is a Sankey diagram?: A Sankey diagram shows how money flows through a company from revenue to net profit. The width of each flow represents its proportion.
How is the data calculated?: We use the income statement from company filings. For TTM (Trailing Twelve Months), we use a pre-aggregated twelve-month view aligned with our latest four quarterly periods. Revenue flows to cost of revenue and gross profit, then to operating expenses (R&D, S&M, G&A) and operating profit.
When was this data last updated?: Based on company filings through TTM through Q1 2026.